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SUMMARY
Formation of the mitotic cleavage furrow is dependent upon both microtubules and activity of the
small GTPase RhoA. GEF-H1 is a microtubule-regulated exchange factor that couples microtubule
dynamics to RhoA activation. GEF-H1 localized to the mitotic apparatus in HeLa cells, particularly
at the tips of cortical microtubules and the midbody, and perturbation of GEF-H1 function induced
mitotic aberrations, including asymmetric furrowing, membrane blebbing, and impaired cytokinesis.
The mitotic kinases Aurora A/B and Cdk1/Cyclin B phosphorylate GEF-H1, thereby inhibiting GEF-
H1 catalytic activity. Dephosphorylation of GEF-H1 occurs just prior to cytokinesis, accompanied
by GEF-H1-dependent GTP-loading on RhoA. Using a live cell biosensor, we demonstrate distinct
roles for GEF-H1 and Ect2 in regulating Rho activity in the cleavage furrow, with GEF-H1 catalyzing
Rho activation in response to Ect2-dependent localization and initiation of cell cleavage. Our results
identify a GEF-H1-dependent mechanism to modulate localized RhoA activation during cytokinesis
under the control of mitotic kinases.
INTRODUCTION
GEF-H1 and its mouse homologue Lfc represent novel members of the Dbl family of guanine
nucleotide exchange factors (GEFs) with RhoA-specific enzymatic activity (Krendel et al.,
2002; Ren et al., 1998). Subcellular localization analysis demonstrated that GEF-H1 is
associated with microtubules (MTs), and that MT depolymerization leads to GEF-H1
activation, accompanied by a RhoA-dependent reorganization of the actin cytoskeleton
(Krendel et al., 2002). Thus, GEF-H1 regulation by MTs provides a novel mechanism to link
RhoA-controlled cellular activities to MT depolymerization. Because GEF-H1 activity is
dependent on the polymerization state of MTs, we speculated that the extensive MT
rearrangements that occur during mitosis might affect GEF-H1 and, thereby, RhoA signaling.
The small GTPase RhoA plays a central role in regulating the formation of the acto-myosin
cleavage furrow (CF) during cell division. When RhoA is depleted genetically or through
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biochemical means, formation of the CF is prevented (Dean et al., 2005; Drechsel et al.,
1997; Kishi et al., 1993; O’Connell et al., 1999). Moreover, the localization of RhoA activity
to a precisely bounded zone seems to be critical for formation of the contractile apparatus
necessary for cell cleavage (Bement et al., 2005). CF formation thus results from the local
activation of RhoA in many cell types (Piekny et al., 2005). However, in Rat-1 (Yoshizaki et
al., 2004) and Rat-2 (Bakal et al., 2005) cells, inhibition of RhoA does not prevent cytokinesis,
but appears to exert effects on early mitotic spindle formation. Thus, the requirements for RhoA
during cytokinesis appear to vary from cell type to cell type.
Studies manipulating the position or the integrity of the mitotic spindle have indicated that
spindle MTs send CF initiation signals to the cell cortex to regulate the assembly and function
of the contractile ring (Alsop and Zhang, 2004; Hamilton and Snyder, 1983; Rappaport,
1997). In particular, astral MTs emanating from the spindle poles, and antiparallel MT bundles
between separating chromosomes (i.e. the midzone spindle) have crucial roles in activating
cortical regions, most likely by controlling localized activation of RhoA at the cell equator
(Bringmann, 2005; Canman et al., 2003; D’Avino et al., 2005; Dechant and Glotzer, 2003;
Glotzer, 2004; Mandato et al., 2000; Strickland et al., 2005). However, the MT-regulated
signals and mechanistic principles underlying RhoA activation during cytokinesis are poorly
understood.
Since small GTPase activation requires the action of specific GEFs, it is conceivable that MT
signaling may impinge on Rho-selective GEFs. Ect2 represents such an activator for Rho
GTPases that has been implicated in cell division (Tatsumoto et al., 1999). There is
accumulating evidence that the primary role of Ect2 is to ensure the localized concentration of
RhoA at the CF (Kamijo et al., 2006 Nishimura, 2006 #1145; Yuce et al., 2005). However,
whether Ect2 catalytic activity is required to activate RhoA during cytokinesis in mammalian
cells remains unclear.
Cdk1/Cyclin B and Aurora kinases have emerged as major regulators of mitotic progression
through their ability to phosphorylate numerous critical mitotic modulators (Ferrari, 2006;
Nigg, 1995; Nigg, 2001). Several lines of evidence have implicated mitotic kinases in the
control of RhoA activity during cell division. Cdk1/Cyclin B modulates the activity of Ect2
during cytokinesis (Hara et al., 2006; Niiya et al., 2006), while phosphorylation by Aurora B
is required to confer RhoA-specific GAP-activity to MgcRacGAP in the same context
(Minoshima et al., 2003). In the present work we show that GEF-H1 is phosphorylated during
mitosis by both Aurora A/B and Cdk1/Cyclin B, and that phosphorylation of GEF-H1 during
M-phase coincides with reduced catalytic activity. GEF-H1 dephosphorylation occurs at the
onset of cytokinesis, and is accompanied by GEF-H1-dependent GTP-loading on RhoA.
Perturbation of endogenous GEF-H1 by both gene knock down and overexpression of
inhibitory mutants caused impairment of HeLa cell cytokinesis. Examination of RhoA
activation dynamics in HeLa cells stably expressing a FRET-based RhoA biosensor indicate
an important regulatory role for GEF-H1 in the activation of RhoA during cytokinesis.
RESULTS
GEF-H1 subcellular distribution correlates with CF formation
Using affinity purified antibodies specific for GEF-H1 (Zenke et al., 2004), we observed that
GEF-H1 accumulates at the mitotic spindle during cell division (Fig. S1, A). Detailed analysis
of the subcellular distribution of GEF-H1 during mitosis in asynchronous HeLa cells revealed
that a substantial fraction of GEF-H1 localizes to the spindle apparatus throughout all stages
of mitosis (Fig. 1, A). During telophase, a subset of GEF-H1 immunoreactivity was enriched
in a narrow equatorial band comprised of aligned short segments at sites of CF formation, most
likely representing overlapping plus ends of equatorial astral MTs (Fig. 1, A; telophase I). With
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the furrow advancing inwards, GEF-H1 segments became more condensed into a ring-like
structure encompassing the midzone (Fig. 1, A; telophase II). Interestingly, our GEF-H1
antibodies did not stain the central spindle, suggesting that GEF-H1 distribution is restricted
to astral and kinetochore MTs (see also Fig. 1, B). Further examination using laser scanning
confocal microscopy showed that GEF-H1 immunoreactivity is enriched at the tips of spindle
MTs (Fig. 1, B; tubulin panels and Fig. S1, C,D). We noticed that MT tip-localized GEF-H1
was more efficiently detected by a phosphorylation-specific GEF-H1 antibody (Fig. 1, B;
pGEF-H1 panels) than by a non-phospho GEF-H1 antibody (Fig. S1, C), possibly due to
differences in epitope accessibility upon phosphorylation (see below). To visualize GEF-H1
distribution relative to centromeres, we stained metaphase and telophase cells with human
CREST serum, which detects the centromere protein CENP-A (Fig. 1, B; CREST panels). In
metaphase cells GEF-H1-positive dots at MTs aligned juxtaposed to the centromeres. Later in
telophase, when the chromosomes moved pole wards, GEF-H1 dots became compacted into a
single band in the midzone region. Double labeling experiments revealed that GEF-H1 and
actin form a double-ring structure (Fig. 1, C; merge channel) composed of an internal GEF-
H1 immunoreactive circle (Fig. 1, C; green channel) associated with the tubulin cytoskeleton,
and aligned with the inner face of the contractile acto-myosin ring (Fig. 1, C; red channel).
Together, these results indicate that GEF-H1 localizes to structures critical for CF formation
and ingression, i.e. cortical MTs and the midbody region.
Perturbation of GEF-H1 function causes defects in cytokinesis
If GEF-H1 is an important regulator of contractile ring formation and cytokinesis, then
perturbation of endogenous GEF-H1 function should increase the extent of multinucleation as
an indicator of failed cytokinesis. Indeed, siRNA-mediated depletion of endogenous GEF-H1
significantly increased the formation of multinucleated cells (18.9 % ± 6.4%) compared with
control (CTRL) siRNA-transfected cells (8.4 % ± 3.7 %) (Fig. 2, A). As a positive control for
multinucleation we also depleted cells of Ect2: similar to previously published studies (Kim
et al., 2005), the number of nuclei was markedly increased in Ect2-siRNA treated cells (55%
± 5.3%, see also Supp. Material).
To corroborate the siRNA depletion data, we analyzed the consequences of overexpression of
GEF-H1 inhibitory mutants on cell division. Fig. 2B shows that overexpression of a non-MT-
associated, enzymatically inactive GEF-H1 mutant (EGFP-GEF-H1C53R+DHmut) had a
greater effect on multinucleation than a MT-associated d/n EGFP-GEF-H1DHmut construct
(26.9% ± 4.9 % vs 12.6 % ± 2.4 %, compared to 3.8 % ± 1.1% for EGFP alone-expressing
cells). These findings are consistent with data showing that d/n GEF-H1 mutants defective in
MT binding block endogenous RhoA activation more efficiently than do MT-bound forms,
supporting the idea that endogenous GEF-H1 is most active when released from the tubulin
cytoskeleton (Krendel et al., 2002;Zenke et al., 2004). Thus, both multinucleation caused by
ablation of endogenous GEF-H1 and via overexpression of GEF-H1 inhibitory mutants suggest
that perturbation of GEF-H1 impairs cytokinesis.
GEF-H1 depletion induces membrane instability and ectopic furrowing during cytokinesis
Prolonged synchronization with nocadazole (noc) was frequently associated with cell death in
GEF-H1 siRNA-treated cells (Fig. S2, B). Under milder conditions in which the apoptotic
phenotype was attenuated (see Methods), we still observed that more cells displayed cortical
aberrations during early mitotic stages when exposed to GEF-H1 siRNA (Fig. 3, b), although
the majority of cells progressed to later stages of mitosis, and chromosome alignment,
segregation and furrow initiation appeared normal in both GEF-H1- and control-depleted cells
(Fig. S8 and Supp. Movies 1-3). As the furrow started to constrict, about 2/3 of the progressing
GEF-H1-depleted cells (i.e. 40.8 % of all cells) exhibited membrane aberrations, including
excessive cortical blebbing and the formation of unstable ectopic furrows (Fig. 3, c-e; Supp.
Birkenfeld et al. Page 3













Movie 2). Interestingly, uncoordinated furrowing and plasma membrane instabilities did not
necessarily culminate in cytokinesis failure. Instead, ectopic furrows regressed or joined with
a robust central furrow, while other uncoordinated membrane activities along the cortex
abrogated upon daughter cell separation (24.8 % ± 4.7%; instability, c panel).
In about 16 % ± 6 % of GEF-H1-depleted cells, abnormal membrane activities could not be
compensated and caused impairment of daughter cell abscission and separation, leading to the
formation of multinucleated cells (20 out of 144 cells; cytokinesis failure, d panels;
supplementary Movie 3) or total collapse of the daughter cells (3 out of 144 cells; e panels).
In contrast, the vast majority of cells expressing control siRNA did not exhibit membrane
instabilities, and passed normally through cell division (regular, a panel). Although some
blebbing occurred in control cells, it was much less pronounced than observed upon GEF-H1
ablation, and was usually confined to the cell poles. Down-regulation of Ect2 induced severe
cytokinetic defects, where 38.4 % ± 1 % (n=54 cells) of the cells analyzed were not able to
perform cleavage (not shown). Multinucleation in this case, however, was not associated with
cortical instabilities but solely with defects in CF formation and ingression (Fig. S3). Overall,
these results indicate distinct roles for Ect2 and GEF-H1 in cytokinesis and suggest that Ect2
is essential for early events occurring during CF induction whereas GEF-H1 activity is
important to coordinate cortical activities during CF ingression.
GEF-H1 is phosphorylated early in mitosis by Aurora A kinase
Using phospho-specific antibodies raised against the pSer885 epitope, we observed high levels
of endogenous phospho-GEF-H1 in lysates from noc-arrested mitotic HeLa cells (Fig. 4, A;
upper panel), with concomitant increase in 14-3-3 binding (Fig. S5, B). In contrast, GEF-H1
phosphorylation and 14-3-3 binding was nearly undetectable in asynchronous HeLa cell
lysates. When synchronized HeLa cells were allowed to progress through mitosis, a dramatic
decrease in the amount of phosphorylated GEF-H1 was observed at 90 min after release, when
the majority of cells entered telophase and underwent cytokinesis (Gohla et al., 2005) (Fig 4,
A; lower panel). Dephosphorylation of GEF-H1 coincided with proteolysis of cyclin B1, which
starts at meta-/anaphase and is required for M phase exit (Clute and Pines, 1999).
Phosphorylation of GEF-H1 at Ser885 was no longer detectable 180 min after release from the
noc block, when most of the cells were in G1 phase. These results demonstrate that GEF-H1
is phosphorylated early during mitosis and undergoes specific dephosphorylation prior to the
final stages of cell division.
Examination of the subcellular distribution of Ser885-phosphorylated GEF-H1 in mitotic cells
showed that immunoreactivity specifically accumulated at the polar regions of the spindle
apparatus (Fig. 4, B and Fig. S4, A). This suggested that GEF-H1 might be phosphorylated by
kinases associated with centrosomal structures such as Aurora A (Andrews et al., 2003). As
shown in Fig. 4C, phospho-GEF-H1indeed accumulated in Aurora A positive double spots
which correspond to the duplicated centrosomes. In contrast, these structures were poorly
stained using non-phospho-GEF-H1 antibody, perhaps due to steric hindrance of antibody
access. We therefore verified the presence of GEF-H1 in centrosomes after EGFP-GEF-H1
plasmid microinjection into thymidinesynchronized HeLa cells (Fig. 4, D). Since phospho-
GEF-H1 antibodies and EGFP-GEF-H1 minimally stained centrosomes of interphase cells (not
shown), this suggests that GEF-H1 is recruited to centrosomes during early mitotic events,
perhaps coincident with phosphorylation by Aurora A.
We next tested whether endogenous Aurora A kinase and GEF-H1 form a complex in live
cells. Immunoprecipitation of GEF-H1 resulted in co-precipitation of Aurora A kinase (Fig. 4,
E), while no co-precipitation was observed from GEF-H1-depleted cell lysates or with control
IgG. In addition, Ser885 phosphorylation of GEF-H1 in vivo was abolished by blocking the
activities of the centrosomal kinases Aurora A and the Cdk1/Cyclin B complex but not by PKA
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or GSK3 β (Fig. 5) indicating that GEF-H1 phosphorylation during mitosis involves the mitotic
kinases Aurora A/B and Cdk1/Cyclin B. We also found that inhibition of Aurora B, a paralogue
of Aurora A that localizes to centromeres, abolished GEF-H1 phosphorylation later in mitosis
(see Fig. S4, D). In vitro kinase assays showed that Aurora A directly phosphorylates GEF-H1
at Ser885 while Cdk1/Cyclin B (or Aurora B) surprisingly modified Ser959 instead (Fig S4,
C,D). Together, these results indicate specific interactions between Aurora A and GEF-H1
during cell division and identify the C-terminus as the major phosphoacceptor region on GEF-
H1.
GEF-H1 is activated by dephosphorylation to promote GTP loading on RhoA
We examined whether phosphorylation could regulate the enzymatic activity of GEF-H1 in
mitotic cells. Using calyculin A, a cell permeable inhibitor of protein phosphatases, we
increased the levels of phosphorylated EGFP-GEF-H1 in transfected cells (Fig. 6, A). EGFP-
GEF-H1 immunoprecipitates from these cells were then treated with calf intestinal phosphatase
(CIP) ± phosphatase inhibitors, and used to catalyze the exchange of GDP for [35S]GTPγS on
RhoA. While immunoprecipitates with high amounts of phospho-GEF-H1 did not catalyze
nucleotide exchange on RhoA (Fig. 6, B; CIP+Inh), the dephosphorylation of GEF-H1
coincided with a dramatic increase in nucleotide exchange activity (Fig. 6, B; CIP), similar to
the maximum exchange obtainable.
To determine whether phosphorylation of GEF-H1 at Ser885and/or Ser959 regulated GEF-H1
activity in the context of mitosis, we expressed GEF-H1 phosphorylation mutants in
metaphase-synchronized HeLa cells and measured GTP-bound RhoA. The increase in GTP-
RhoA observed in mitotic lysates expressing wildtype GEF-H1 (compare with EGFP control)
was used as a reference (Fig.6,C = 100%). Overexpression of the phosphomimetic S885D
single mutant significantly increased GTP-RhoA as compared to cells expressing EGFP alone,
while the S959D single mutant also increased GTP-RhoA, but was somewhat less active (Fig.
6, C). Phosphorylation-deficient GEF-H1 S885A and S959A mutants also induced RhoA
activation similar to WT GEF-H1 (Fig.S5,C). In contrast, overexpression of the
phosphomimetic double mutant SS885/959DD clearly did not significantly increase GTP-
RhoA over control levels. These data suggest that both Aurora A and Cdk1/Cyclin B-mediated
phosphorylation are necessary for full negative regulation of GEF-H1 activity during early
stages of mitosis.
The phosphorylation of Ser885 in GEF-H1 is known to induce binding of 14-3-3 protein to
GEF-H1 (Zenke et al., 2004), and we observed that 14-3-3 was associated with GEF-H1 in
mitotic cell lysates (Fig.S5,B). Thus, part of the inhibitory effect of Aurora A-induced Ser885
phosphorylation in vivo may result from the stimulation of 14-3-3 binding to GEF-H1.
GEF-H1 depletion alters RhoA activation dynamics during cytokinesis in live cells
GEF-H1 is not phosphorylated and thereby most probably exists as an active form during
telophase, a time-point when mitotic cells form the CF in a RhoA-dependent manner. To test
whether GEF-H1 is involved in the activation of RhoA in telophase, we depleted HeLa cells
of endogenous GEF-H1 and Ect2 using siRNA. Similar to cells in interphase (Fig. S6, B), GEF-
H1 expression in mitotic cells was suppressed by approximately 79% (± 15, 8 %), while Ect2
siRNA-induced knock down was nearly complete, with 4% (± 3,4 %) protein expression
remaining (Fig. 7, A; graph). Determination of GTP-RhoA accumulation in synchronized,
siRNA-treated cells showed that control siRNA-treated cells exhibited increased GTP-bound
RhoA during telophase (Fig. 7, A + B; CTRL siRNA). Depletion of Ect2 did not alter GTP-
RhoA formation during telophase (Ect2 siRNA), which was surprising considering the known
requirement for Ect2 to localize RhoA to the equatorial cortex prior to CF ingression. In
contrast, GEF-H1 depletion led to a strong reduction in the amount of activated RhoA during
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telophase, while RhoA activation remained largely unaffected during pro- and metaphase
(GEF-H1 siRNA). However, for both GEF-H1- and Ect2-ablated cells, high levels of RhoA
activation were detected at 180 min, further suggesting hampered exit from mitosis. Taken
together, these data indicate that GEF-H1 is involved in the activation of RhoA during
cytokinesis.
To test the hypothesis that GEF-H1-induced mitotic aberrations involve perturbed RhoA
activation, we generated cells stably expressing a single chain FRET-based biosensor that
responds to GTP-loading on RhoA (Pertz et al., 2006) (Fig. 7, C). Analogous to endogenous
RhoA in TCA-fixed cells (Yonemura et al., 2004), CFP fluorescence of the biosensor
concentrates at the equatorial cortex at the onset of furrowing (Fig. 7, D; CFP panel, anaphase)
and during membrane ingression (telophase I + II), indicating that it likely reflects regulation
of endogenous RhoA. We examined spatio-temporal changes in the activity of HeLa cell RhoA
during cytokinesis (Figs. 7, E and S10). Images were taken from biosensor-expressing cells
that entered anaphase, as evidenced by initiation of chromosome separation. The emission ratio
FRET/CFP was used to represent RhoA activation, as described (Pertz et al., 2006). In control
cells, activated RhoA was found to accumulate at the equatorial cortex during anaphase (Fig.
7, E; CTRL siRNA, FRET panel, time point 0). As furrowing progressed, RhoA activity
increased in the CF, reaching a peak level in the late phase of cytokinesis when the midbody
matrix was formed and daughter cells started to separate (13 out of 15 cells analyzed) (here,
time point 21.42). In cells treated with GEF-H1 siRNA, early cortical activation of RhoA was
not affected (Fig. 7, E; GEF-H1 siRNA, FRET panel, time points 0-10.17). However, as
constriction proceeded, RhoA activation in the forming CF decreased. Of particular interest,
in 62% of the cells analyzed (8 out of 13), localized RhoA activation was strongly diminished
at late stages of cytokinesis shortly before midbody formation, although RhoA protein was still
concentrated at sites of cleavage as in control cells (CFP + FRET panels, time points
12.06-19.20). The loss of localized RhoA activation in the CF was correlated with dramatic
cortical blebbing and aberrant membrane activities, as described (Fig. 3). (See also Fig.S10).
In contrast, in Ect2-depleted cells CFP fluorescence of the RhoA biosensor was no longer
accumulated at equatorial sites of CF formation (Ect2 siRNA, CFP panels). Instead, the
biosensor was randomly distributed along the cell periphery, correlated with strong but
unlocalized cortical activation of RhoA throughout all stages of mitosis analyzed (Ect2 siRNA,
FRET panels) (5 out of 6 cells analyzed). RhoA activation in the CF was only marginal (FRET
panel, time points 19.20-22.24). Concomitantly, CF formation and constriction was either
markedly slowed (Fig. 7, E; Ect2 siRNA, DIC panels) or incomplete and often resulted in
regression of the CF and binucleated cells (See Fig. S10; Ect2 siRNA, DIC panels. See also
Fig. S3, b). In combination with the pull-down activity assay data presented, these results
demonstrate distinct roles for GEF-H1 and Ect2 in RhoA activation during cytokinesis. While
Ect2 appears to initially direct the localization of RhoA protein to equatorial sites prior to CF
formation, GEF-H1 participates in GTP-loading of RhoA after furrowing has been induced.
DISCUSSION
GEF-H1 localization may link cortical activation of RhoA to MTs
MT-derived signals are important for RhoA translocation to and activation at the equatorial
cortex to allow positioned assembly and contraction of the acto-myosin CF (Bement et al.,
2005). We have shown in this study that GEF-H1 meets important requirements for a regulator
of RhoA activation at the cell cortex. First, GEF-H1 localizes to the tips of cortical MTs of the
mitotic spindle, thereby placing its catalytic activity in close proximity to the cell cortex (Fig.
1). Second, as the mitotic spindle becomes compressed by the ingressing cortex, short GEF-
H1 immunoreactive segments in the equatorial plane adopt a condensed circular structure that
is aligned with the inner face of the acto-myosin contractile ring. A similar structure has been
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described in Drosophila that is made up of GAP50C-PAV, linking the MT network with the
acto-myosin contractile ring through interaction with the Ect2 homolog Pbl (Somers and Saint,
2003). GEF-H1 could therefore represent another structural element to link MTs with the cell
cortex in mammalian cells.
GEF-H1 is a target of Aurora A and Cdk1/Cyclin B kinases during early mitosis
In the present work we established the mitotic kinases Aurora A/B and Cdk1/Cyclin B as
important regulators of GEF-H1 activity during cell division. We identified Ser885 of GEF-H1
as the principle phospho-acceptor site for Aurora A (Fig. S4, B) and Ser959 as the primary
Cdk1/Cyclin B GEF-H1 phosphorylation site. It is possible that upon mitotic entry
phosphorylation by Cdk1/Cyclin B induces a conformational change in the GEF-H1 C-terminal
regulatory domain allowing Aurora A to access and phosphorylate Ser885, which would be
otherwise masked by structural constraints. Similar regulation has been described for Ect2 in
which pre-phosphorylation by Cdk1/Cyclin B stimulated the association of Ect2 with Polo-
like kinase 1, likely by releasing Ect2 from intramolecular auto-inhibitory interactions (Hara
et al., 2006).
Reducing GEF-H1 phosphorylation by phosphatase treatment resulted in increased guanine
nucleotide exchange activity of wt GEF-H1 (Fig. 6, B). Consistently, phosphomimetic
Ser885D/Ser959D double mutants of GEF-H1 significantly exhibited less RhoA activation in
mitotic lysates (Fig. 6, C). We conclude that phosphorylation of GEF-H1 during cell division
negatively regulates its enzymatic activity. Our results do not address whether phosphorylation
might inhibit GEF-H1 activity by affecting MT binding. However, the reduction in exchange
activity may involve 14-3-3 protein binding induced by Ser885 phosphorylation (Zenke et al.,
2004), as we have observed association of 14-3-3 with GEF-H1 in mitotic cell
immunoprecipitates (Fig.S5, B). Since MT depolymerization rapidly activates GEF-H1 to
enhance cell contractility (Krendel et al., 2002), GEF-H1-induced contractions would likely
interfere with cortical stabilization required for mitotic cell rounding. Given that the interphase-
mitosis transition is accompanied by a rapid breakdown of the cytoplasmic MT network (Zhai
et al., 1996), immediate inactivation of GEF-H1 (by phosphorylation) may be necessary for
mitotic rounding.
GEF-H1 and Ect2 mediate different aspects of RhoA activation during cytokinesis
Ect2 is essential for RhoA localization at the equatorial cortex, a prerequisite for CF formation
and ingression (Nishimura and Yonemura, 2006; Yuce et al., 2005). Inhibition of Ect2 often
relies on overexpression of the inhibitory N-terminus (Saito et al., 2004), and mitotic cells
expressing Ect2-N show reduced RhoA activation during cytokinesis (Kimura et al., 2000). It
is not clear however, if the reduced GTP-loading on RhoA is due to interference with Ect2
exchange activity, as opposed to the activation and/or localization of other GEFs (e.g. GEF-
H1) that might be triggered by full-length Ect2. Accordingly, N-terminal mutants of Ect2 that
retained full GEF activity in vitro failed to rescue the cytokinesis defect in cells depleted of
endogenous Ect2 , suggesting that recruitment of additional regulators apart from Ect2
exchange activity itself is crucial for RhoA activation. We observed that siRNA-mediated
depletion of Ect2, while quite effective (see Fig.S6), did not interfere with bulk RhoA activation
during telophase (Fig. 7, A and B), also indicating that Ect2 does not directly activate RhoA.
In clear contrast, while inhibition of GEF-H1 did not affect recruitment of RhoA and other
regulators of cytokinesis to cortical regions (Fig. 7, E and Fig. S7), ablation of GEF-H1 caused
a strong decrease in overall RhoA activation during telophase (Fig. 7, A and E). Furthermore,
we observe that the activation profile of GEF-H1 during mitosis is inversely correlated to that
of Ect2. While GEF-H1 is inhibited during early stages of mitosis and is activated by
dephosphorylation during cytokinesis (this study), phosphorylation increases the catalytic
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activity of Ect2 in vitro (Tatsumoto et al., 1999) and in M-phase cells (Hara et al., 2006;Niiya
et al., 2006). This indicates distinct roles for GEF-H1 and Ect2 during cell division.
Inhibition of GEF-H1 causes late defects in cytokinesis that correlate with decreased RhoA
activation at the CF
Using time-lapse video microscopy, we identified aberrations during CF formation in cells
treated with GEF-H1-specific RNAi duplexes. A majority of the GEF-H1-depleted cells
demonstrated loss of membrane stability in the CF during late stages of mitosis after normal
furrow induction (Fig. 3; panel c and d). These perturbations did not necessarily coincide with
cytokinesis failure, as membranous aberrations often subsided, and a compact midbody bridge
formed (Fig. 3, panel c). The membrane phenotype observed here is reminiscent of the
depletion of either the actin bundling protein, anillin, or the RhoA effector, citron kinase
(D’Avino et al., 2004;Echard et al., 2004), whose down-regulation led to reduced cortical
stability of the cleavage plane and, later, the intercellular midbody bridge (Echard et al.,
2004). This resulted in the loss of membrane attachment to this structure, causing a blebbing
phenotype. As GEF-H1 might be important for both linking cortical components (e.g. anillin-
bundled actin filaments of the contractile ring) to the mitotic spindle, as well as regulating the
activity of RhoA effector proteins in the context of contractile ring formation and ingression,
our findings are consistent with GEF-H1 RNAi-induced aberrations of the CF.
Using a FRET-based biosensor, we detected high RhoA activity at sites of constriction and in
the CF during all stages of cytokinesis (Fig. 7, E and S10). In contrast, Yoshizaki et al. were
not able to detect high levels of RhoA activation in the CF of HeLa cells using their FRET-
based Raichu-RhoA probes (Yoshizaki et al., 2003). These conflicting observations may be
explained by the inherent insensitivity of Raichu probes to RhoGDI regulation, as well their
constitutive localization to membranes (Nakamura et al., 2005; Yoshizaki et al., 2003;
Yoshizaki et al., 2004). The localization of the RhoA biosensor (Pertz et al., 2006) used in this
study coincides with that of endogenous RhoA, perhaps due to its normal binding to RhoGDI,
which controls reversible RhoA membrane targeting (DerMardirossian and Bokoch, 2005). In
fact, RhoGDI activity appears to be important for RhoA function during cytokinesis, since cells
lacking RhoGDI are multinucleated (Rivero et al., 2002). We conclude that the patterns of
RhoA activity we detect reflect the endogenous RhoA activation profile and, hence, increase
in the CF during cytokinesis.
GEF-H1 ablation in HeLa cells causes a decrease in RhoA activation during late stages of
cytokinesis as demonstrated in this paper by FRET- and RBD-affinity-based assays (Fig. 7, A
and E). Early cortical RhoA activation was, however, not perturbed by reducing GEF-H1
protein levels. Therefore, GEF-H1 may act as a modulator of late mitosis to ensure that midbody
formation and daughter cell abscission occur correctly. From this perspective, GEF-H1 might
be involved in sustaining high RhoA activity in the CF to ensure contractility and cortical
stiffness (O’Connell et al., 1999). By providing cortical tension in the CF, this would also
guarantee that polarized daughter cell spreading is initiated from the poles and migration occurs
in opposite directions. Loss of tension in the CF would consequently coincide with plasma
membrane instabilities, especially as new membrane material might still be added to the CF
to adjust the normally high furrow cortical tensions. Reduced RhoA activation in the CF caused
by GEF-H1 depletion is therefore consistent with the observed membrane perturbations during
cell cleavage. In contrast to our results, Bakal et al (Bakal et al., 2005) observed that Lfc, the
mouse homolog of GEF-H1, had an early influence on mitotic spindle assembly in Rat-2 cells.
We clearly established here that early mitotic effects, including mitotic spindle formation, are
not observed upon disruption of GEF-H1 function in HeLa cells (Fig. S8). We note that Bakal
et.al. did not directly assess the regulation of RhoA activity in Rat-2 cells by Lfc, precluding
comparisons of how RhoA activation might influence the phenotypic differences observed.
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However, such differences in GEF-H1/Lfc function may be accounted for by a number of
variables, including differences in the adherent properties of the cells used, in regulatory
mechanisms modulating GEF activity, or by intrinsic differences in mitotic mechanisms that
have been noted between cells (Burgess and Chang, 2005).
Our data also establish that Ect2 and GEF-H1 mediate different aspects of RhoA activation at
the cell cortex in HeLa cells. Bulk RhoA activation is not affected by Ect2 depletion, and RhoA
activation appears to be mislocalized, rather than diminished (Fig.7,E and S10). This suggests
that Ect2 does not directly catalyze GTP-loading on RhoA during cytokinesis. We propose that
Ect2 serves as a core signaling platform essential for the recruitment of important modules of
the cleavage machinery such as RhoA and its regulators to equatorial sites (see Fig. S9).
Interactions of Ect2 with several components implicated in the regulation of acto-myosin-based
contractility of the CF are known (Chalamalasetty et al., 2006;Kamijo et al., 2006;Yuce et al.,
2005). Consequently, loss of Ect2 would cause delocalization of cleavage factors from the
equator, resulting in dispersed RhoA activation around the cortex. In good agreement, as a
result of Ect2 siRNA treatment RhoA activation is no longer concentrated at the CF and
becomes scattered around the cell cortex, as indicated by our FRET experiments. We suggest
that once a RhoA-containing signaling complex is assembled and activated at the cell cortex
in a MT- and Ect2-dependent manner, RhoA cycling is intensified by localized activation of
GTPase regulators such as GEF-H1. Accordingly, perturbation of GEF-H1 was accompanied
by late cytokinetic defects but did not affect localization of RhoA and other regulators of
cytokinesis (Fig. S7).
Since CF induction was not affected by GEF-H1 depletion, this also suggests the existence of
additional RhoA activators. Recently, a new exchange factor, MyoGEF, (Wu et al., 2006) was
identified that associates with non-muscle myosin II and whose depletion also causes
multinucleation. For the future, it will be interesting to analyze how different RhoA GEFs are
coordinated through MTs, mitotic kinases, and associated signaling factors to modulate and
fine tune different aspects of mammalian cell contractile ring formation and constriction.
MATERIALS AND METHODS
Expression constructs
EGFP-GEF-H1 full length constructs in the mammalian expression vector pCMV5 and GST-
tagged individual domain constructs of GEF-H1 in the bacterial expression vector pGEX-KG
have been described (Krendel et al., 2002; Zenke et al., 2004). An EGFP-GEF-H1 C53R/
Y393A construct was generated by inserting a N-terminal KpnI/BstBI fragment including the
C53R mutation into KpnI/BstBI cut pCMV5-EGFP-GEF-H1 DHmut vector which contained
the Y393A mutation (Krendel et al., 2002). Phospho-mimetic (S885D, S959D, SS885/959DD)
and non phosphorylatable GEF-H1 mutants (S885A, S959A, SS885/959AA) were generated
by site-directed mutagenesis and confirmed by sequencing.
Antibodies
Generation and affinity purification of the polyclonal anti-GEF-H1 antibody used in this study
has been described (Zenke et al., 2004). The polyclonal anti-pS885 GEF-H1 antibody was from
Cell Signaling Technology. Both anti-GEF-H1 antibodies were used at 1:1000 in immunoblots
and 1:100 in IF experiments. Additional antibodies used in this work are detailed in the Supp.
Methods.
RNAi interference
GEF-H1- and Ect2-directed pools of four individual siRNA duplex oligonucleotides
(SMARTpool® reagent) were purchased from Dharmacon RNA Technologies (Lafayette, CO)
Birkenfeld et al. Page 9













and selected according to the SMARTselection algorithm (see Supp. Methods). siRNA pools
were transfected using LipofectAmine 2000 (Invitrogen), as indicated in the Supp. Methods.
Cell culture, DNA transfections, synchronization and drug treatments
HeLa cells were cultured in Dulbecco’s modified Eagle’s medium containing 8% fetal bovine
serum, 10 mM glutamine, 10 mM Hepes and antibiotics (100 U/ml penicillin G, and 100 μg/
ml streptomycin). For biochemical analysis, cells were grown in 10 cm dishes and transfected
with 5-10μg EGFP-tagged GEF-H1 constructs using LipofectAmine 2000 per the
manufacturer. For immunostaining, HeLa cells were grown on glass in 24-well plates and
transfected with 0.1-0.5μg of plasmid DNA using LipofectAmine Plus reagent (Invitrogen),
per manufacturer’s recommendations.
Cell synchronization in prometaphase was achieved by the thymidine/nocadazole method and
mitotic cells processed as previously described, with minor modifications (Gohla et al.,
2005) – see Supp. Methods.
Aurora A kinase activity was inhibited with 5 μM ZM477439 (kindly provided by Astra
Zeneca), Aurora B with 0.5 μM Hesperadin (a gift of Boehringer Ingelheim), Cdk1/Cyclin B
with either 10 μM Purvalanol A (Calbiochem) or 200 nM BMI-1026 (kindly provided by
Kyung Lee, NCI), protein kinase A was blocked with 10 μM H89 (Calbiochem), and GSK3
with 10 μM SB216763 (Tocris). Solvent (DMSO) controls were performed in parallel.
Immunofluorescence and microscopy
For microscopic observations, HeLa cells were grown on glass coverslips in 24-well plates in
DMEM containing 8% fetal calf serum and transfected as described above. For localization of
endogenous GEF-H1, cells were fixed in ice-cold MeOH or MeOH/acetone (50:50) for 20 min.
To enhance visualization of GEF-H1 at MTs, soluble cellular components were extracted for
30 sec in extraction buffer (80 mM Pipes, pH 6.8, 1 mM MgCl2, 4 mM EGTA, 10 μM Taxol,
0.5% (w/v) Triton X-100) prior to fixation. To stain for endogenous RhoA, cells were fixed in
10% TCA at 4°C (Yonemura et al., 2004). Cells were processed for immunofluorescence
staining according to (Gohla et al., 2005) using Alexa-488 and Alexa-568 secondary antibody
conjugates. DNA was visualized with DAPI (1:2000; Sigma). Quadruple stainings were
obtained using biotinylated-phalloidin together with Alexa-750-labelled streptavidin in
accordance with the manufacturer’s suggestions (Molecular Probes).
Dominant negative (d/n) GEF-H1 mutants were transfected as above and fixed in ice-cold
MeOH. Only those cells that expressed the EGFP-fusion proteins of interest at comparable
levels (similar to cells expressing EGFP alone) were scored. For this study, multinucleated
cells were defined as cells with more than one nucleus, including lobulated-, macro- and
micronuclei (Gohla et al., 2005).
Live cell imaging
Live cell imaging of dividing cells was performed in a sealed chamber at 37°C on a Nikon
TE2000-U microscope with a 40x/1.3 oil objective and DIC optics. Multi dimensional
acquisition was controlled by MetaMorph software. For RNAi experiments, cells were
transfected with siRNA duplexes for 24 h and then synchronized with 100ng/ml noc for 6-9
h. After a 45 min release period in fresh medium, mitotic cells were imaged every 20 sec for
a period of 7 h.
RhoA activation in dividing cells
A HeLa cell line stably expressing a RhoA-biosensor (Pertz et al., 2006) was generated by co-
transfecting 4μg RhoA-biosensor plasmid DNA together with 1μg of pPURO vector
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(Clontech). Stable clonal populations were isolated based on puromycin resistance and YFP
fluorescence, then further purified by cell sorting (FACS). FRET imaging was performed as
described (Pertz et al., 2006) – see also Supp. Methods.
Wildtype Hela cells or HeLa cells transfected for 24 h with EGFP-GEF-H1 constructs or siRNA
were synchronized with thymidine/noc or noc alone, respectively (see text) and released for
the indicated times in fresh medium prior to performing Rhotekin RBD pull-down assays to
quantify GTP-RhoA (Ren and Schwartz, 2000).
Kinase assays
Active His-tagged Aurora A/B and Cdk1/Cyclin B kinases were purchased from Upstate Cell
Signaling Solutions. In vitro phosphorylation assays were carried out as described (Knaus et
al., 1995) - See Supp. Methods for details.
Phosphatase treatment, (co)-immunoprecipitation and in vitro exchange assays
Phosphatase treatments, chemical cross-linking with DSP, coimmunoprecipitation and in
vitro exchange assays are detailed in the Supp. Methods or as described elsewhere (Downward,
1995; Krendel et al., 2002; Zenke et al., 2004).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Subcellular localization of endogenous GEF-H1 during mitosis
(A)GEF-H1 is associated with the spindle apparatus throughout mitosis. Asynchronous HeLa
cells were fixed with methanol/acetone and quadruple-stained for endogenous GEF-H1 (red
channel), tubulin (green channel), actin (blue channel) and DNA (yellow). Scale bar represents
20 μm.
(B) GEF-H1 localizes to the tips of cortical MTs. Asynchronous HeLa cells were extracted for
soluble tubulin, fixed as above and stained using anti-pGEF-H1 (green), anti-tubulin (red)
antibodies or CREST serum. Boxed regions are shown in higher magnification. Confocal
micrographs (single slices of 0.54 μm thickness) were analyzed for colocalized data points
(displayed as white overlays in the colocalization panel).
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(C) During cytokinesis, GEF-H1 forms an equatorial ring encompassed by contractile actin
structures. Confocal microscopy of mitotic HeLa cells stained with anti-GEF-H1 (green) and
anti-actin (red) antibodies. Indicated regions (white arrows) are shown in higher magnification
in the inserts.
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Fig. 2. Multinucleation caused by GEF-H1 perturbation
(A) Multinucleated cells were found at 48 h after transfection with GEF-H1 siRNA. Values
shown are the means from four independent experiments in which over 1000 cells were counted
per experiment; error bars indicate SEM. For statistical analysis, all data were evaluated by
two-tailed Student’s t-test. Values significantly different from controls (p≤ 0.01) are marked
with an asterisk. Cells harboring more than 1 nucleus are indicated by an asterisk in the
micrograph. Scale bar represents 20 μm.
(B) Overexpression of GEF-H1 inhibitory mutants induced multinucleation. The number of
the multinucleated cells as a percentage of the total cell population expressing the EGFP-tagged
constructs was quantified in HeLa cells 48 h after transfection. A minimum of 100 cells from
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each of three independent experiments was scored for each construct. Values significantly
different from EGFP-expressing cells are marked with one (p≤0.01) or two asterisks (p ≤0.001).
Micrographs on the right illustrate expression patterns of the different constructs.
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Fig. 3. Downregulation of GEF-H1 causes mitotic aberrations
Distribution of mitotic phenotypes in GEF-H1 (GEF-H1 siRNA) or control siRNA (CTRL
siRNA)-transfected cells. Classification of phenotypes: a) regular cytokinesis; b) collapsing:
cortical hyperactivity during metaphase, finally collapsing; c) instability: membranous
aberrations around the CF w/o impairment of cytokinesis; d) failed cytokinesis: membranous
aberrations during cytokinesis that are not compensated and gave rise to cytokinesis failure.
Values are given as percentage of total cells with error bars indicating ± SEM. Actual numbers
are indicated. In four independent experiments, a total of 144 GEF-H1-depleted and 114
control-depleted cells were scored (*≤ 0.05; **≤ 0.005; *** ≤0.0005).
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Fig. 4. Association of GEF-H1 with Aurora A
(A) Upper panel: GEF-H1 is phosphorylated at the onset of mitosis. HeLa cells were incubated
with 100ng/ml noc for 16 h. Rounded mitotic cells, harvested by mechanical knock-off (mit.)
and remaining adherent interphase cells (int.) were lysed and analyzed by immunoblotting with
anti-pGEF-H1 or anti-GEF-H1 antibodies. Lysates from asynchronous (async.) or Pak1-
transfected (PAK1; pSer885 control) HeLa cells were used as controls. Lower panel:
Dephosphorylation of GEF-H1 during telophase/cytokinesis. HeLa cells were synchronized in
mitosis by thymidine and noc, collected by knock-off and replated on poly-L-lysine-coated
culture dishes. Lysates were analyzed by anti-pGEF-H1 or anti-GEF-H1 immunoblotting at
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the indicated time points. The degradation of Cyclin B was used as an additional marker for
cell synchrony. 14-3-3 zeta controls were included to confirm comparable protein loading.
(B) Immunolocalization of Ser885-phosphorylated GEF-H1 in mitotic cells. Asynchronous
HeLa cells were fixed and stained for GEF-H1 (red channel), tubulin (green channel) and DNA
(DAPI) as described in Fig.1. Scale bar represents 20 μm.
(C) pGEF-H1 colocalizes with Aurora A in centrosomes. HeLa cells in prophase were co-
stained for Aurora A (red channel) and either GEF-H1 or pGEF-H1 (green channels). DNA
was detected by DAPI staining. Yellow color (merged image) indicates co-localization of
pGEF-H1 with Aurora A in centrosomes.
(D) Centrosome localization of EGFP-GEF-H1. HeLa cells were microinjected with plasmid
DNA encoding EGFP-GEF-H1 and analyzed by time-lapse video fluorescence microscopy.
Arrows indicate the position of the centrosomes.
(E) GEF-H1 interacts with Aurora A in vivo. Immunoprecipitation of GEF-H1-depleted (GEF-
H1 siRNA) or control-depleted (CTRL siRNA) mitotic lysates with either anti-GEF-H1
antibodies or control IgG after DSP crosslinking. The resulting immunoprecipitates were
isolated, separated on SDS-PAGE, and immunoblotted with anti-Aurora A antibody. Lysate
lanes shown represent ten percent of input lysate.
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Fig. 5. Phosphorylation of GEF-H1 by mitotic kinases Aurora A and Cdk1/Cyclin B
Inhibition of Aurora kinases and Cdk1/Cyclin B abolish GEF-H1 phosphorylation during
mitosis. Before adherence, harvested synchronized HeLa cells were inhibitor treated for 15
min during release into fresh culture medium (w/o nocodazole) supplemented with the same
inhibitors (at denoted concentrations and specificities). Inhibitors used here are specific for
serine-threonine kinases that are either predicted by the Scansite algorithm (scansite.mit.edu)
to phosphorylate GEF-H1 (PKA, GSK3β; data not shown) or are required for the control and
timing of mitotic progression (Aurora A/B, Cdk1/Cyclin B) (Ferrari, 2006; Nigg, 2001). At
the indicated times (after adherence), cells were lysed and analyzed by anti-pGEF-H1 and anti-
GEF-H1 immunoblotting.
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Fig. 6. Dephosphorylation stimulates GEF-H1 enzymatic activity
(A) Calyculin A induces phosphorylation of GEF-H1 in vivo. HeLa cells were treated with
100nM Calyculin A or DMSO for 45 min. The amount of phospho-GEF-H1 in the different
lysates was analyzed by immunoblotting with anti-pGEF-H1 antibodies.
(B) Increase of GEF-H1 guanine nucleotide exchange activity in vitro after dephosphorylation.
EGFP-GEF-H1 immunoprecipitates from Calyculin A-stimulated HeLa cells were treated with
calf intestine alkaline phosphatase (CIP) in the presence (CIP+inh) or absence (CIP) of
phosphatase inhibitors and subjected to in vitro GEF-assays as in Methods. The level of
nucleotide binding in the presence of EDTA was set to 100%. pGEF-H1 levels in the
immunoprecipitates after CIP treatment were analyzed by anti-pGEF-H1 immunoblotting
(insert). Each value represents the mean (± SEM) of three independent experiments. Asterisk
indicates values significantly different from EDTA controls (p≤ 0.0001).
(C) Effects of GEF-H1 derivatives on accumulation of GTP-bound RhoA during mitosis. HeLa
cells were transfected with the indicated EGFP-tagged expression vectors coding for different
GEF-H1 mutants or EGFP alone for 24 h. Following a 15 h synchronization period with 100ng/
ml noc, cells were released into fresh medium for 45min prior to lysis. Subsequently, the GTP-
bound fraction of RhoA was extracted from the lysates by GST-RBD. The amount of RhoA
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bound to GST-RBD (GTP-RhoA) and the level of RhoA expression (total RhoA) in whole cell
lysates was determined by immunoblotting using anti-RhoA antibodies. RhoA activation was
expressed as percent activation relative to the EGFP-GEF-H1 wt-transfected control (set to
100%). Each datapoint represents the mean (± SEM) of at least three independent experiments.
Asterisk indicates values significantly different from EGFP-GEF-H1wt controls (p ≤0.01). The
dashed line marks the level of GTP-RhoA in EGFP-expressing cells. All values were
normalized for expression efficiency of the individual constructs (anti-EGFP immunoblotting)
and total RhoA levels by densitometric analysis as in (A). PonceauS staining was used to
determine the amount of GST-RBD in the reaction.
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Fig. 7. GEF-H1 modulates RhoA activation in mitotic cells
(A + B) Cell cycle-associated changes in the level of GTP-RhoA after GEF-H1 depletion.
Synchronized HeLa cells were subjected to GST-RBD pull down assays to detect GTP-RhoA
during different stages of mitosis in lysates depleted of GEF-H1, Ect2 or control-depleted
lysates. A representative experiment is shown in (A). At least four independent assays for each
condition were used to quantify the activation profile of RhoA as inFig. 6D (B). The amount
of GTP-RhoA at 45 min after noc release was set to 100%. All values were normalized for the
total amount of RhoA. Error bars indicate ± SEM. (A; graph) The remaining expression of
GEF-H1 and Ect2 in the mitotic lysates was quantitated densitometrically after immunoblotting
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and normalized to CTRL-siRNA treated cells. Values represent the mean of four independent
determinations ±SEM. Note that Ect2 ablation was more efficient than depletion of GEF-H1.
(C) HeLa cells stably transfected with a FRET-based RhoA biosensor were analyzed for
expression of the latter by live microscopy (upper panels; CFP channel) and immunoblotting
of respective lysates using anti-RhoA antibodies (lower panel). Biosensor expression was ~2-
fold increased over endogenous RhoA levels as determined by densitometric analysis.
(D) Localization of the RhoA biosensor in live cells during cytokinesis. The subcellular
distribution of the RhoA biosensor in live cells (CFP panel) was compared to that of
endogenous RhoA in TCA-fixed cells during different stages of mitosis. Fixed cells were
stained with anti-RhoA (green) and anti-tubulin (red) antibodies and DAPI (blue) for DNA.
(E) RhoA activation patterns during cytokinesis. HeLa cells stably expressing the RhoA
biosensor were transfected with the indicated siRNAs for 30 h before progression through
cytokinesis was analyzed by DIC microscopy and FRET/CFP ratio imaging to represent FRET
efficiency (FRET). The localization of the biosensor is shown in the CFP channel. FRET
pictures denote activation patterns of the biosensor. All images are processed and scaled
identically so that regions of intense RhoA activity are shown in red. The elapsed time is
denoted at the bottom right corners of each picture. A representative image of at least 6 similar
images acquired for each condition is shown. White arrows indicate equatorial regions with
high RhoA activation in CTRL-depleted cells and reduced RhoA activation in GEF-H1 and
Ect2 siRNA-treated cells during late stages of cytokinesis. Asterisks indicate regions of
aberrant membrane activities in cells treated with GEF-H1 siRNA.
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